SECURITIES AND EXCHANGE COMMISSION
  
  Washington, DC  20549
  
  FORM 8-K
  
  CURRENT REPORT    
  
  Pursuant to Section 13 or 15(d) of the
  Securities Exchange Act of 1934
  
  October 3, 1994
  
  Mallinckrodt Group Inc.
  (Exact name of registrant as specified in its charter)
  
  
  New York               
  (State or other jurisdiction of incorporation)                  
   
  1-483
  (Commission File Number)
  
  36-1263901
  (IRS Employer Identification No.)
  
  7733 Forsyth Boulevard, St. Louis, MO           
  (Address of principal executive offices)              
  
  63105-1820
  (Zip Code)
  
  Registrant's telephone number including area code
  (314) 854-5200
  
  
    <PAGE>
Item 5. Other Events
  A press release was issued October 3, 1994.  The text of that
  release is as follows:
  
  MALLINCKRODT NAMES PRESIDENT FOR VETERINARY COMPANY;
  FORMER MERCK EXECUTIVE BRINGS STRONG INDUSTRY EXPERIENCE
  
  ST. LOUIS, MISSOURI, October 3, 1994 -- Mallinckrodt Group Inc.
  (NYSE:MKG) announced today that Paul D. Cottone, formerly vice
  president of U.S. operations for the Merck AgVet Division, has
  joined Mallinckrodt Veterinary as president and chief executive
  officer, effective October 1.  Cottone also will serve as a
  senior vice president of Mallinckrodt Group.
  
  "We are extremely pleased to have attracted an animal health
  industry executive of this caliber," said C. Ray Holman,
  Mallinckrodt Group president and chief executive officer. 
  "Paul has extensive knowledge of the animal health industry,
  strong U.S. and international experience in both the animal and
  human health industries, and a solid business and management
  portfolio with accountability for total operations for major
  business segments.  Mallinckrodt's firm commitment to our
  animal health business is even stronger today with an
  individual of Cottone's stature at the helm."
  
  Cottone said, "I share the Mallinckrodt management team's
  enthusiasm for the future of the animal health business, look
  forward to building on the leadership position the company has
  established over many years and am firmly committed to
  achieving financial objectives that are expected to contribute
  to the growth and success of the company."
  
  Cottone's seven years of experience with Merck AgVet included
  six years as executive director, international operations,
  which included Canada, Australia, New Zealand, South Africa,
  and Japan.  In 1993, he was promoted to the position of vice
  president, U.S. operations with the division.
  
  He joined Merck Sharp & Dohme in 1972 and for four years sold
  human health products to doctors and hospitals.  He
  subsequently held several product management sales and
  marketing positions until 1982, when he was named director of
  marketing and sales - MSD Australia.  Cottone later was
  managing director - MSD New Zealand and director of
  Pharmaceutical operations - MSD Brazil.  In 1986, he was named
  senior director, U.S. Regional Operations.
  
  A native of Brooklyn, New York, Cottone has a B.S. degree in
  pharmacy from Fordham University (New York) and did post-
  graduate work in the MBA program at Fairleigh Dickinson
  University (New Jersey).  He is a member of the board of
  directors of the Animal Health Institute.
  
  Mallinckrodt Group, a St. Louis-based Fortune 250 company, has
  fiscal net sales of $1.94 billion.  Through its three
  technology-based businesses -- Mallinckrodt Chemical and
  Mallinckrodt Medical, also headquarter in the St. Louis area,
  and Mallinckrodt Veterinary, headquartered in Mundelein,
  Illinois -- the company provides specialty chemicals and human
  and animal health products.  Mallinckrodt has 10,200 employees
  worldwide.
  
  
  Pursuant to the requirements of the Securities Exchange Act of
  1934, the registrant has duly caused this report to be signed
  on its behalf by the undersigned thereunto duly authorized.
  
  Mallinckrodt Group Inc.
  
  
  ROGER A. KELLER
  Vice President, Secretary and General Counsel
  
  DATE:   October 19, 1994
[{"type": "8-K", "sequence": "1", "secsgml_size_bytes": 4098}]
{"company-data": {"conformed-name": "MALLINCKRODT GROUP INC", "cik": "0000051396", "assigned-sic": "2834", "irs-number": "361263901", "state-of-incorporation": "NY", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-00483", "film-number": "94553976"}, "business-address": {"street1": "7733 FORSYTH BOULEVARD", "city": "ST LOUIS", "state": "MO", "zip": "63105", "phone": "314-854-5299"}, "mail-address": {"street1": "7733 FORSYTH BLVD", "city": "ST. LOUIS", "state": "MO", "zip": "63105-1820"}, "former-company": [{"former-conformed-name": "IMCERA GROUP INC", "date-changed": "19920703"}, {"former-conformed-name": "INTERNATIONAL MINERALS & CHEMICAL CORP", "date-changed": "19900614"}]}
SECURITIES AND EXCHANGE COMMISSION
  
  Washington, DC  20549
  
  FORM 8-K
  
  CURRENT REPORT    
  
  Pursuant to Section 13 or 15(d) of the
  Securities Exchange Act of 1934
  
  October 3, 1994
  
  Mallinckrodt Group Inc.
  (Exact name of registrant as specified in its charter)
  
  
  New York               
  (State or other jurisdiction of incorporation)                  
   
  1-483
  (Commission File Number)
  
  36-1263901
  (IRS Employer Identification No.)
  
  7733 Forsyth Boulevard, St. Louis, MO           
  (Address of principal executive offices)              
  
  63105-1820
  (Zip Code)
  
  Registrant's telephone number including area code
  (314) 854-5200
Item 5. Other Events
  A press release was issued October 3, 1994.  The text of that
  release is as follows:
  
  MALLINCKRODT NAMES PRESIDENT FOR VETERINARY COMPANY;
  FORMER MERCK EXECUTIVE BRINGS STRONG INDUSTRY EXPERIENCE
  
  ST. LOUIS, MISSOURI, October 3, 1994 -- Mallinckrodt Group Inc.
  (NYSE:MKG) announced today that Paul D. Cottone, formerly vice
  president of U.S. operations for the Merck AgVet Division, has
  joined Mallinckrodt Veterinary as president and chief executive
  officer, effective October 1.  Cottone also will serve as a
  senior vice president of Mallinckrodt Group.
  
  "We are extremely pleased to have attracted an animal health
  industry executive of this caliber," said C. Ray Holman,
  Mallinckrodt Group president and chief executive officer. 
  "Paul has extensive knowledge of the animal health industry,
  strong U.S. and international experience in both the animal and
  human health industries, and a solid business and management
  portfolio with accountability for total operations for major
  business segments.  Mallinckrodt's firm commitment to our
  animal health business is even stronger today with an
  individual of Cottone's stature at the helm."
  
  Cottone said, "I share the Mallinckrodt management team's
  enthusiasm for the future of the animal health business, look
  forward to building on the leadership position the company has
  established over many years and am firmly committed to
  achieving financial objectives that are expected to contribute
  to the growth and success of the company."
  
  Cottone's seven years of experience with Merck AgVet included
  six years as executive director, international operations,
  which included Canada, Australia, New Zealand, South Africa,
  and Japan.  In 1993, he was promoted to the position of vice
  president, U.S. operations with the division.
  
  He joined Merck Sharp & Dohme in 1972 and for four years sold
  human health products to doctors and hospitals.  He
  subsequently held several product management sales and
  marketing positions until 1982, when he was named director of
  marketing and sales - MSD Australia.  Cottone later was
  managing director - MSD New Zealand and director of
  Pharmaceutical operations - MSD Brazil.  In 1986, he was named
  senior director, U.S. Regional Operations.
  
  A native of Brooklyn, New York, Cottone has a B.S. degree in
  pharmacy from Fordham University (New York) and did post-
  graduate work in the MBA program at Fairleigh Dickinson
  University (New Jersey).  He is a member of the board of
  directors of the Animal Health Institute.
  
  Mallinckrodt Group, a St. Louis-based Fortune 250 company, has
  fiscal net sales of $1.94 billion.  Through its three
  technology-based businesses -- Mallinckrodt Chemical and
  Mallinckrodt Medical, also headquarter in the St. Louis area,
  and Mallinckrodt Veterinary, headquartered in Mundelein,
  Illinois -- the company provides specialty chemicals and human
  and animal health products.  Mallinckrodt has 10,200 employees
  worldwide.
  
  
  Pursuant to the requirements of the Securities Exchange Act of
  1934, the registrant has duly caused this report to be signed
  on its behalf by the undersigned thereunto duly authorized.
  
  Mallinckrodt Group Inc.
  
  
  ROGER A. KELLER
  Vice President, Secretary and General Counsel
  
  DATE:   October 19, 1994